CClinicalTrials.gg
CompletedNCT05092971Updated May 22, 2024Results posted

Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients

An interventional study of Shock or startle device in Anxiety and Healthy Volunteers, sponsored by National Institute of Mental Health (NIMH). Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-22.

Sponsored by National Institute of Mental Health (NIMH) · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Background:

Research has shown that anxiety affects more than feelings. It also affects behavior. Researchers want to learn how the brain and body respond to unexpected threats. They want to see if probable pleasant or unpleasant events change decisions.

Objective:

To better understand how changes in anxiety are associated with changes in decision-making.

Eligibility:

Adults aged 18-50 with generalized anxiety disorder, seasonal affective disorder, or panic disorder. Healthy volunteers are also needed.

Design:

Participants will be screened under protocol #01-M-0254.

Participants will complete surveys about their anxiety, risk-taking, and curiosity.

Participants will complete a computer task. They will be given different choices. They will make a choice. They will receive an unpleasant or pleasant stimulus based on their choice. They will repeat this task many times.

Most participants will do the task in the clinic. The unpleasant stimulus will be electric shock and acoustic startle. They will receive electric shocks through electrodes placed on their arm or fingers. They may hear loud noises through headphones. Their eyeblinks will be recorded with electrodes placed under their eye. Their heart rate and skin conductance activity will be collected with electrodes as well.

Some healthy volunteers will do the task during a functional magnetic resonance imaging scan. They will lie on a table that slides in and out of a scanner. A coil will be placed over their head. The unpleasant stimulus will be electric shock, given as stated above. The scanner will record their brain activity. Their breathing and pulse rate will be recorded as well.

Participation will last for 3-4 hours.

Read the detailed description

Study Description:

This study s goal is to identify parameters of interest in decision making in the context of anxiety disorders, using theoretical models in healthy volunteers (HV) and anxiety patients (AD). Participants are asked to complete a decision-making task, namely the Multi-armed Bandit Task.

The study will be conducted in the clinic. Participants (HV and AD) are asked to fill out questionnaires and complete the Multi-armed Bandit Task. An electric shock is used as the aversive stimulus. Monetary reward is used as the reward stimulus. Additionally, physiological signals (Heart rate, skin conductance activity, startle) are collected during the course of the task. In addition, in a pilot study, participants startle responses for varying shock parameters are recorded and analyzed.

Objectives:

The primary objective of this study is to use theoretical models in healthy volunteers (HV) and patients with an anxiety disorder (AD) to better understand how changes in anxiety are associated with changes in decision making. In addition, this study will ascertain whether decision making parameters correlate with certain behavioral measures such as trait and state anxiety using (i) questionnaires, (ii) physiological measures.

Endpoints:

The primary endpoint of this study is a significant difference in model derived parameters between experimental manipulations (conditions) and/or population groups. The parameters of interest include: 1) Learning Rate, 2) Exploration parameter, 3) Discount rate, 4) Loss aversion, 5) Inverse Temperature.

The secondary endpoints are a significant correlation between functions of model derived parameters and behavioral and/or physiological measures of anxiety including:

  1. Questionnaire scores
  2. Startle
  3. Skin conductance
02

Conditions studied

  • Anxiety
  • Healthy Volunteers

Browse trials for

Keywords

  • functional magnetic resonance imaging (fMRI)
  • multi-arm bandit task
  • anxiety volunteers
  • Healthy Volunteers
03

In context

Anxiety Disorders

4,864 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.

This study's enrollment of 51 is below the median of 80 across 4,170 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

National Institute of Mental Health (NIMH) is the lead sponsor of 359 studies on the registry; 46 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 24 (96%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  1. Provision of signed and dated informed consent form
  2. Male or female, aged 18-50, inclusive
  3. Patients only: Primary Diagnostic and Statistical Manual (DSM) 5 diagnoses of an anxiety disorder (GAD, social anxiety disorder (SAD), panic disorder)

Exclusion criteria

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Non-English speaking individual
  2. Pregnancy or positive pregnancy test
  3. Any significant medical or neurological problems as determined by investigators (e.g.cardiovascular illness, respiratory illness, neurological illness, seizure, etc.)
  4. Current or past serious mental disorders (e.g., bipolar or psychotic disorders) (except for anxiety and depressive disorders in patients)
  5. Current alcohol or substance use disorder
  6. History of moderate or severe alcohol or substance use disorder within one year prior to screening
  7. Current or past significant organic central nervous system disorders as determined by investigators, including but not limited to seizure disorder or neurological symptoms of the wrist and arm (e.g., carpal tunnel syndrome) for shocks to be delivered on affected arm.
  8. Positive urine toxicology screen at screening visit under 01-M-0254
  9. Employees of National Institute of Mental Health (NIMH) or an immediate family member of a NIMH employee.
  10. Healthy volunteers only: Current DSM-5 disorders.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Anxiety patient

    Participants with anxiety completed computer tasks. They were given different choices and had to make choice(s). The objective was to find the optimal choice by sampling through the choices. They received an unpleasant or pleasant stimulus based on their choice(s). They repeated these tasks many times.

    Device: Shock or startle device

  • Experimental
    Healthy volunteer

    Healthy volunteers completed computer tasks. They were given different choices and had to make choice(s). The objective was to find the optimal choice by sampling through the choices. They received an unpleasant or pleasant stimulus based on their choice(s). They repeated these tasks many times.

    Device: Shock or startle device

Interventions

  • DeviceShock or startle device

    Shock and startle devices were used as aversive stimulus (shock and startle)

06

What researchers measure

Primary outcomes

  1. Difference in Learning Rate

    Learning rate is a hyperparameter that quantifies the degree to which subjects update their beliefs in response to feedback. The outcome examined the difference in learning rate between experimental manipulation (condition) and population (healthy and anxiety subjects). During the multi-arm bandit task, participants choose from a set of choices and update their belief of the value of the choices based on prior choices with some choices having a higher probability of shock (punishment) than reward. The changes in learning rate were measured using the learning rate algorithm. The difference in learning rate was analyzed using a 2-way ANOVA with condition and population. The learning rate (α) range between 0 and 1. The higher the value, the faster rate of learning. However, a higher learning rate may also result in lower generalization capability.

    Time frame: End of experiment (3-4 hours in a single day visit)

07

Results

Posted May 22, 2024

Participant flow

Participant flow — Overall Study
MilestoneAnxiety PatientHealthy Volunteer
Started2031
Completed2031
Not completed00

Outcome measures

PrimaryDifference in Learning Rate

Learning rate is a hyperparameter that quantifies the degree to which subjects update their beliefs in response to feedback. The outcome examined the difference in learning rate between experimental manipulation (condition) and population (healthy and anxiety subjects). During the multi-arm bandit task, participants choose from a set of choices and update their belief of the value of the choices based on prior choices with some choices having a higher probability of shock (punishment) than reward. The changes in learning rate were measured using the learning rate algorithm. The difference in learning rate was analyzed using a 2-way ANOVA with condition and population. The learning rate (α) range between 0 and 1. The higher the value, the faster rate of learning. However, a higher learning rate may also result in lower generalization capability.

Time frame:
End of experiment (3-4 hours in a single day visit)
Reported as:
Mean · unitless
Difference in Learning Rate
unitlessAnxiety PatientHealthy Volunteer
Difference in Learning Rate0.009 ± 0.03150.0058 ± 0.037

Adverse events

Collected over One day. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Anxiety Patient0/20 (0%)0/20 (0%)0/20 (0%)
Healthy Volunteer0/31 (0%)0/31 (0%)0/31 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Anxiety PatientHealthy VolunteerTotal
<=18 years000
Between 18 and 65 years203151
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Anxiety PatientHealthy VolunteerTotal
Female191837
Male11314
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Anxiety PatientHealthy VolunteerTotal
Hispanic or Latino516
Not Hispanic or Latino153045
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Anxiety PatientHealthy VolunteerTotal
American Indian or Alaska Native000
Asian2810
Native Hawaiian or Other Pacific Islander000
Black or African American358
White121729
More than one race213
Unknown or Not Reported101
08

Study locations

1 site
  • National Institutes of Health Clinical Center
    Bethesda, Maryland 20892, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 1, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — De-identified data will be shared to a repository. Identified individual participant data will not be shared.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05092971
Lead sponsor
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Oct 26, 2021
Start date
Mar 3, 2022
Primary completion
Jul 28, 2022
Completion
Jul 28, 2022
Results posted
May 22, 2024
Last update
May 22, 2024

Study contacts

Maryland Pao, M.D.
principal investigator · National Institute of Mental Health (NIMH)

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion